After a dull Q4, Glenmark Pharma needs a booster shot to grow

Glenmark Pharma's future growth hinges on strong operational performance, moving beyond past licensing deals, which means investors should closely monitor their core business execution. This shift emphasizes fundamental business strength over short-term gains, impacting investment decisions.